<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.napwa.org.au" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>resistance tests</title>
 <link>http://www.napwa.org.au/treating-hiv/tests/resistance-tests</link>
 <description>Customised to include nested data</description>
 <language>en-au</language>
<item>
 <title>Genotype tests get final Budget approval</title>
 <link>http://www.napwa.org.au/pl/2011/06/genotype-tests-get-final-budget-approval</link>
 <description> &lt;p&gt;Good news from this year’s Budget is the decision to list the HIV genotype test as a funded Medicare item.&lt;/p&gt;
&lt;p&gt;Approval of the test, which measures drug &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistance&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt;, has been promoted long and hard by both community and &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/475&quot;&gt;&lt;span&gt;clinical&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;Pertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science.&lt;/span&gt; groups as a vital tool in Australia’s HIV treatment arsenal.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2011/06/genotype-tests-get-final-budget-approval&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <enclosure url="http://www.napwa.org.au/image/view/2642/preview" length="412082" type="image/jpeg" />
 <pubDate>Wed, 25 May 2011 23:02:37 -0700</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">2643 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Treatments news from the IAS Conference</title>
 <link>http://www.napwa.org.au/pl/2009/09/treatments-news-from-the-ias-conference</link>
 <description> &lt;p&gt;A roundup of HIV treatments developments from the IAS Conference in Cape Town.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2009/09/treatments-news-from-the-ias-conference&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nrtis/abacavir">abacavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/protease-inhibitors/atazanavir">atazanavir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/nnrtis/nevirapine">nevirapine</category>
 <category domain="http://www.napwa.org.au/living-with-hiv/positive-women/pregnancy-and-childbirth">pregnancy and childbirth</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/integrase-inhibitors/experimental-treatments">raltegravir</category>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <pubDate>Wed, 19 Aug 2009 18:52:42 -0700</pubDate>
 <dc:creator />
 <guid isPermaLink="false">1793 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Resistance</title>
 <link>http://www.napwa.org.au/resource/hiv-tests-and-treatments/antiviral-treatments/resistance</link>
 <description> &lt;p&gt;Every time HIV reproduces itself there’s a high chance that it may ‘mutate’ slightly. A ‘mutation’ is a small alteration in the genetic makeup. These alterations may make the &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/125&quot;&gt;&lt;span&gt;virus&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A small infective organism which is incapable of reproducing outside a host cell.&lt;/span&gt; more &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/109&quot;&gt;&lt;span&gt;resistant&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;HIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant.&lt;/span&gt; to an individual drug or potentially a class of drug.The more the virus is reproducing (i.e. the higher the &lt;a class=&quot;glossary-term&quot; href=&quot;/glossary/term/416&quot;&gt;&lt;span&gt;viral load&lt;/span&gt;&lt;/a&gt;&lt;span class=&quot;hovertip&quot;&gt;A measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma.&lt;/span&gt;) the more chances there are of mutations occurring.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/resource/hiv-tests-and-treatments/antiviral-treatments/resistance&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/anet">ANET resources</category>
 <category domain="http://www.napwa.org.au/understanding-hiv-treatments/treating-hiv/salvage-therapy/understanding-hiv-treatments/drug-resista">drug resistance</category>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <pubDate>Thu, 06 Aug 2009 21:22:52 -0700</pubDate>
 <dc:creator>Graham Stocks</dc:creator>
 <guid isPermaLink="false">1762 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Australia risks being &#039;stuck in the past&#039; on HIV treatment</title>
 <link>http://www.napwa.org.au/media/2007/07/23/australia-risks-being-stuck-in-the-past-on-hiv-treatment</link>
 <description> &lt;p&gt;Australia&#039;s reputation as a world leader in HIV/AIDS treatment is at risk due to the failure of the Australian government to fund a key diagnostic test, the National Association of People Living with HIV/AIDS (NAPWA) has warned.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/media/2007/07/23/australia-risks-being-stuck-in-the-past-on-hiv-treatment&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/accessing-hiv-care-and-treatment/medicare">Medicare</category>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <pubDate>Mon, 23 Jul 2007 15:00:00 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">634 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>News and treatments briefs</title>
 <link>http://www.napwa.org.au/pl/2007/03/news-and-treatments-briefs</link>
 <description> &lt;p&gt;HIV-related news in brief from the March 2007 edition of &lt;cite&gt;Positive Living&lt;/cite&gt;.&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2007/03/news-and-treatments-briefs&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/maturation-inhibitors/experimental-treatment">bevirimat (MPC-4326, PA-457)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/complementary-and-alternative-therapies">complementary and alternative therapies</category>
 <category domain="http://www.napwa.org.au/living-with-hiv/sex-and-relationships/disclosure">disclosure</category>
 <category domain="http://www.napwa.org.au/treating-hiv/healthy-living/nutrition">nutrition</category>
 <category domain="http://www.napwa.org.au/defeating-hiv/hiv-prevention/preventative-vaccines">preventative vaccines</category>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <pubDate>Wed, 21 Mar 2007 07:06:27 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">615 at http://www.napwa.org.au</guid>
</item>
<item>
 <title>Rescue me</title>
 <link>http://www.napwa.org.au/pl/2005/04/rescue-me</link>
 <description> &lt;p&gt;What are the options when you&amp;rsquo;re running out of options?&lt;/p&gt;
 &lt;p&gt;&lt;a href=&quot;http://www.napwa.org.au/pl/2005/04/rescue-me&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/adherance">adherance</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments-0">darunavir</category>
 <category domain="http://www.napwa.org.au/understanding-hiv-treatments/treating-hiv/salvage-therapy/understanding-hiv-treatments/drug-resista">drug resistance</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments/entry-inhibitors/t-20">enfuvirtide (T-20)</category>
 <category domain="http://www.napwa.org.au/treating-hiv/hiv-treatments">HIV treatments</category>
 <category domain="http://www.napwa.org.au/treating-hiv/tests/resistance-tests">resistance tests</category>
 <category domain="http://www.napwa.org.au/treating-hiv/understanding-hiv-treatments/salvage-therapy">salvage therapy</category>
 <category domain="http://www.napwa.org.au/treating-hiv/treating-hiv/hiv-treatments/hiv-treatments/protease-inhibitors/experimental-treatments">tipranavir</category>
 <enclosure url="http://www.napwa.org.au/image/view/821/preview" length="31714" type="image/jpeg" />
 <pubDate>Wed, 18 May 2005 07:00:11 -0700</pubDate>
 <dc:creator>Paul Kidd</dc:creator>
 <guid isPermaLink="false">151 at http://www.napwa.org.au</guid>
</item>
</channel>
</rss>

